{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:19:28Z","timestamp":1778055568453,"version":"3.51.4"},"reference-count":96,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T00:00:00Z","timestamp":1499644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Itch is the main chief complaint in patients visiting dermatologic clinics and has the ability to deeply impair life quality. Itch results from activation of cutaneous nerve endings by noxious stimuli such as inflammatory mediators, neurotransmitters and neuropeptides, causing itch signal transduction from peripheral skin, through the spinal cord and thalamus, to the brain cortex. Primarily noninflammatory diseases, such as uremic pruritus, cause itch through certain pruritogens in the skin. In inflammatory skin diseases, atopic dermatitis (AD) is the prototypic disease causing intensive itch by aberrant skin inflammation and epidermal barrier disruption. Recent understanding of disease susceptibility, severity markers, and mechanisms have helped to develop targeted therapy for itch in AD, including monoclonal antibodies against IL-4, IL-13, thymic stromal lymphopoietin (TSLP), IgE and IL-31. Promising effects have been observed in some of them. In this review, we summarized targeted therapies for inflammatory itch in AD and for managing abnormal itch transductions in other common itching skin diseases.<\/jats:p>","DOI":"10.3390\/ijms18071485","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T11:05:31Z","timestamp":1499684731000},"page":"1485","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Inflammatory and Noninflammatory Itch: Implications in Pathophysiology-Directed Treatments"],"prefix":"10.3390","volume":"18","author":[{"given":"Lai-San","family":"Wong","sequence":"first","affiliation":[{"name":"Department of Dermatology, College of Medicine, Chang Gung Memorial Hospital and Chang Gung University, Kaohsiung 833, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Wu","sequence":"additional","affiliation":[{"name":"Zanvyl Kreiger School of Arts and Sciences, Johns Hopkins University, Baltimore, MD 21287, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Dermatology, College of Medicine, Chang Gung Memorial Hospital and Chang Gung University, Kaohsiung 833, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2017,7,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1001\/archderm.139.11.1463","article-title":"Neurophysiology of pruritus: Cutaneous elicitation of itch","volume":"139","author":"Stander","year":"2003","journal-title":"Arch. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrn1950","article-title":"The neurobiology of itch","volume":"7","author":"Ikoma","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nature06029","article-title":"A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord","volume":"448","author":"Sun","year":"2007","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2011.08.043","article-title":"Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids","volume":"147","author":"Liu","year":"2011","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1126\/science.1233765","article-title":"The cells and circuitry for itch responses in mice","volume":"340","author":"Mishra","year":"2013","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1744-8069-10-4","article-title":"B-type natriuretic peptide is neither itch-specific nor functions upstream of the GRP-GRPR signaling pathway","volume":"10","author":"Liu","year":"2014","journal-title":"Mol. Pain"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.neuron.2010.02.025","article-title":"Loss of inhibitory interneurons in the dorsal spinal cord and elevated itch in Bhlhb5 mutant mice","volume":"65","author":"Ross","year":"2010","journal-title":"Neuron"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-biophys-051013-022826","article-title":"Itch mechanisms and circuits","volume":"43","author":"Han","year":"2014","journal-title":"Annu. Rev. Biophys."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neuron.2014.02.046","article-title":"Dynorphin acts as a neuromodulator to inhibit itch in the dorsal horn of the spinal cord","volume":"82","author":"Kardon","year":"2014","journal-title":"Neuron"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1529-8019.2008.00167.x","article-title":"neuropathic and psychogenic itch","volume":"21","author":"Yosipovitch","year":"2008","journal-title":"Dermatol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/0972-6748.160950","article-title":"Delusional parasitosis with folie a deux: A case series","volume":"24","author":"Sawant","year":"2015","journal-title":"Ind. Psychiatry J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.semnephrol.2015.06.009","article-title":"Pruritus in Kidney Disease","volume":"35","author":"Combs","year":"2015","journal-title":"Semin. Nephrol."},{"key":"ref_13","first-page":"94","article-title":"Prurigo nodularis is associated with depression and anxiety in chronic hemodialysis patients","volume":"29","author":"Tseng","year":"2015","journal-title":"Acta Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ko, M.J., Wu, H.Y., Chen, H.Y., Chiu, Y.L., Hsu, S.P., Pai, M.F., Ju, Y., Lai, C.F., Lu, H.M., and Huang, S.C. (2013). Uremic pruritus, dialysis adequacy, and metabolic profiles in hemodialysis patients: A prospective 5-year cohort study. PLoS ONE, 8.","DOI":"10.1371\/annotation\/43d10c8d-5a10-41c4-ad44-605dfee7f630"},{"key":"ref_15","first-page":"161","article-title":"Uremic pruritus in chronic hemodialysis patients","volume":"21","author":"Narita","year":"2008","journal-title":"J. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.13157","article-title":"Cancer incidence among patients with a hospital diagnosis of pruritus: A nationwide Danish cohort study","volume":"171","author":"Johannesdottir","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_17","first-page":"495","article-title":"Itch: A symptom of occult disease","volume":"33","author":"Hiramanek","year":"2004","journal-title":"Aust. Fam. Physician"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000440829","article-title":"Pathogenesis and Management of pruritus in PBC and PSC","volume":"33","author":"Kremer","year":"2015","journal-title":"Dig. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Xander, C., Meerpohl, J.J., Galandi, D., Buroh, S., Schwarzer, G., Antes, G., and Becker, G. (2013). Pharmacological interventions for pruritus in adult palliative care patients. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD008320.pub2"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1053\/j.gastro.2014.08.042","article-title":"The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice","volume":"147","author":"Lieu","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s15006-016-8449-9","article-title":"Management of pruritus in patients with cholestatic liver disease","volume":"158","author":"Kremer","year":"2016","journal-title":"MMW Fortschr. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1398-9995.2010.01995.x","article-title":"Pathophysiology and therapy of pruritus in allergic and atopic diseases","volume":"65","author":"Buddenkotte","year":"2010","journal-title":"Allergy"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000323307","article-title":"Biomarkers for itch and disease severity in atopic dermatitis","volume":"41","author":"Lee","year":"2011","journal-title":"Curr. Probl. Dermatol."},{"key":"ref_24","first-page":"314","article-title":"Topical calcineurin inhibitors in dermatology","volume":"34","author":"Gutfreund","year":"2005","journal-title":"Postepy Dermatol. Alergol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2016.07.047","article-title":"Ustekinumab treatment in severe atopic dermatitis: Down-regulation of T-helper 2\/22 expression","volume":"76","author":"Weiss","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/exd.13112","article-title":"Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"26","author":"Khattri","year":"2017","journal-title":"Exp. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/sj.bjp.0703472","article-title":"FK506 potently inhibits T cell activation induced TNF-a and IL-1b production in vitro by human peripheral blood mononuclear cells","volume":"130","author":"Sakuma","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/jid.2008.295","article-title":"Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling","volume":"129","author":"Zheng","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"9283","DOI":"10.1523\/JNEUROSCI.5318-12.2013","article-title":"The ion channel TRPA1 is required for chronic itch","volume":"33","author":"Wilson","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0923-1811(03)00148-8","article-title":"Up-regulation of interleukin-13 receptor \u03b11 on human keratinocytes in the skin of psoriasis and atopic dermatitis","volume":"33","author":"Wongpiyabovorn","year":"2003","journal-title":"J. Dermatol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0091-6749(96)70246-4","article-title":"In vivo expression of IL-12 and IL-13 in atopic dermatitis","volume":"98","author":"Hamid","year":"1996","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/thoraxjnl-2014-206719","article-title":"Lebrikizumab in moderate-to-severe asthma: Pooled data from two randomised placebo-controlled studies","volume":"70","author":"Hanania","year":"2015","journal-title":"Thorax"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1398-9995.2005.00791.x","article-title":"Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis","volume":"60","author":"Oldhoff","year":"2005","journal-title":"Allergy"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","article-title":"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice","volume":"5","author":"Dillon","year":"2004","journal-title":"Nat. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/jid.2008.183","article-title":"IL-31 receptor \u03b1 expression in epidermal keratinocytes is modulated by cell differentiation and interferon \u03b3","volume":"129","author":"Heise","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaci.2008.05.047","article-title":"Correlation of IL-31 serum levels with severity of atopic dermatitis","volume":"122","author":"Raap","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: A new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1365-2133.2012.11047.x","article-title":"Mechanistic correlations between two itch biomarkers, cytokine interleukin-31 and neuropeptide \u03b2-endorphin, via STAT3\/calcium axis in atopic dermatitis","volume":"167","author":"Lee","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2013.10.048","article-title":"A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1","volume":"133","author":"Cevikbas","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/all.12316","article-title":"Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge","volume":"69","author":"Hawro","year":"2014","journal-title":"Allergy"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2014.07.008","article-title":"Cytokines as therapeutic targets in skin inflammation","volume":"25","author":"Wittmann","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/jid.2014.51","article-title":"IL-17A as an inducer for Th2 immune responses in murine atopic dermatitis models","volume":"134","author":"Nakajima","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1067\/mai.2003.1414","article-title":"Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions","volume":"111","author":"Toda","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/jid.2008.111","article-title":"Possible pathogenic role of Th17 cells for atopic dermatitis","volume":"128","author":"Koga","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.20051745","article-title":"Thymic stromal lymphopoietin: Master switch for allergic inflammation","volume":"203","author":"Liu","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1399-3038.2009.00919.x","article-title":"Increased serum thymic stromal lymphopoietin in children with atopic dermatitis","volume":"21","author":"Lee","year":"2010","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1073\/pnas.0812668106","article-title":"Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2013.08.057","article-title":"The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch","volume":"155","author":"Wilson","year":"2013","journal-title":"Cell"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Chang, W.C., Lee, C.H., Hirota, T., Wang, L.F., Doi, S., Miyatake, A., Enomoto, T., Tomita, K., Sakashita, M., and Yamada, T. (2012). ORAI1 genetic polymorphisms associated with the susceptibility of atopic dermatitis in Japanese and Taiwanese populations. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0029387"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jaci.2015.12.1342","article-title":"Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials","volume":"137","author":"Zhao","year":"2016","journal-title":"J. Allergy Clin."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jaci.2007.08.060","article-title":"Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels","volume":"120","author":"Belloni","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jdermsci.2014.10.005","article-title":"Antipruritic mechanisms of topical E6005, a phosphodiesterase 4 inhibitor: Inhibition of responses to proteinase-activated receptor 2 stimulation mediated by increase in intracellular cyclic AMP","volume":"76","author":"Andoh","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2142\/biophysics.11.17","article-title":"TRP channels in skin: From physiological implications to clinical significances","volume":"11","author":"Ho","year":"2015","journal-title":"Biophysics"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.npep.2009.10.002","article-title":"Differential effects of substance P or hemokinin-1 on transient receptor potential channels, TRPV1, TRPA1 and TRPM8, in the rat","volume":"44","author":"Sunakawa","year":"2010","journal-title":"Neuropeptides"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1523\/JNEUROSCI.23-15-06176.2003","article-title":"Proteinase-activated receptor-2 mediates itch: A novel pathway for pruritus in human skin","volume":"23","author":"Steinhoff","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1248\/bpb.b13-00333","article-title":"Abnormalities in itch sensation and skin barrier function in atopic NC\/Tnd mice","volume":"36","author":"Amagai","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Gibson, R.A., Robertson, J., Mistry, H., McCallum, S., Fernando, D., Wyres, M., and Yosipovitch, G. (2014). A randomised trial evaluating the effects of the TRPV1 antagonist SB705498 on pruritus induced by histamine, and cowhage challenge in healthy volunteers. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100610"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nn.2789","article-title":"TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch","volume":"14","author":"Wilson","year":"2011","journal-title":"Nat. Neurosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/jid.2009.58","article-title":"Non-neuronal expression of transient receptor potential type A1 (TRPA1) in human skin","volume":"129","author":"Atoyan","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.4049\/jimmunol.1300300","article-title":"TRPA1-dependent pruritus in IL-13-induced chronic atopic dermatitis","volume":"191","author":"Oh","year":"2013","journal-title":"J. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1038\/jid.2010.32","article-title":"Topical application of TRPA1 agonists and brief cold exposure accelerate skin permeability barrier recovery","volume":"130","author":"Denda","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Kim, Y.S., Park, J.H., Choi, S.J., Bae, J.Y., Ahn, D.K., McKemy, D.D., and Bae, Y.C. (2014). Central connectivity of transient receptor potential melastatin 8-expressing axons in the brain stem and spinal dorsal horn. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0094080"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1523\/JNEUROSCI.3976-07.2008","article-title":"Visualizing cold spots: TRPM8-expressing sensory neurons and their projections","volume":"28","author":"Dhaka","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"14841","DOI":"10.1523\/JNEUROSCI.3005-11.2011","article-title":"A role for nociceptive, myelinated nerve fibers in itch sensation","volume":"31","author":"Ringkamp","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1081-1206(10)62868-2","article-title":"A pilot study examining the role of zileuton in atopic dermatitis","volume":"83","author":"Woodmansee","year":"1999","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2165\/00003495-200767160-00003","article-title":"Pathophysiology and management of opioid-induced pruritus","volume":"67","author":"Ganesh","year":"2007","journal-title":"Drugs"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1365-2133.2009.09305.x","article-title":"Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin","volume":"161","author":"Gazerani","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaad.2011.01.016","article-title":"Aprepitant: Evidence of its effectiveness in patients with refractory pruritus continues","volume":"66","author":"Torres","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaad.2004.01.045","article-title":"Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: A pilot study","volume":"50","author":"Hundley","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11255-014-0795-x","article-title":"Comparison of pregabalin with ondansetron in treatment of uraemic pruritus in dialysis patients: A prospective, randomized, double-blind study","volume":"47","author":"Yue","year":"2015","journal-title":"Int. Urol. Nephrol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1681\/ASN.2005020152","article-title":"\u03ba-Opioid system in uremic pruritus: Multicenter, randomized, double-blind, placebo-controlled clinical studies","volume":"16","author":"Wikstrom","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/exd.12626","article-title":"H1-Antihistamines and itch in atopic dermatitis","volume":"24","author":"Church","year":"2015","journal-title":"Exp. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neuron.2006.09.036","article-title":"Phospholipase C\u03b2 3 mediates the scratching response activated by the histamine H1 receptor on C-fiber nociceptive neurons","volume":"52","author":"Han","year":"2006","journal-title":"Neuron"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaci.2011.09.005","article-title":"Histamine and H1-antihistamines: Celebrating a century of progress","volume":"128","author":"Simons","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/exd.12630","article-title":"Olopatadine, a non-sedating H1 antihistamine, decreases the nocturnal scratching without affecting sleep quality in atopic dermatitis","volume":"24","author":"Yamanaka","year":"2015","journal-title":"Exp. Dermatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fphar.2015.00065","article-title":"The histamine H4 receptor: From orphan to the clinic","volume":"6","author":"Thurmond","year":"2015","journal-title":"Front. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neubiorev.2014.07.020","article-title":"Modulation of behavior by the histaminergic system: Lessons from HDC-, H3R- and H4R-deficient mice","volume":"47","author":"Schneider","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2332\/allergolint.13-RA-0675","article-title":"The role of histamine H1 and H4 receptors in atopic dermatitis: From basic research to clinical study","volume":"63","author":"Ohsawa","year":"2014","journal-title":"Allergol. Int."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1254\/jjp.88.351","article-title":"Intradermal cholinergic agonists induce itch-associated response via M3 muscarinic acetylcholine receptors in mice","volume":"88","author":"Miyamoto","year":"2002","journal-title":"Jpn. J. Pharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1468-3083.2001.00278.x","article-title":"The use of antidepressant drugs in dermatology","volume":"15","author":"Gupta","year":"2001","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0190-9622(85)70092-8","article-title":"Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria","volume":"12","author":"Greene","year":"1985","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0306-4522(00)00523-6","article-title":"The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception","volume":"102","author":"Parada","year":"2001","journal-title":"Neuroscience"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2340\/00015555-0553","article-title":"Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: Results of an open-labelled, two-arm proof-of-concept study","volume":"89","author":"Stander","year":"2009","journal-title":"Acta Derm. Venereol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21553","article-title":"Sertraline as a first-line treatment for cholestatic pruritus","volume":"45","author":"Mayo","year":"2007","journal-title":"Hepatology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"363901","DOI":"10.1155\/2012\/363901","article-title":"Effect of sertraline on uremic pruritus improvement in ESRD patients","volume":"2012","author":"Shakiba","year":"2012","journal-title":"Int. J. Nephrol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0885-3924(02)00645-0","article-title":"Mirtazapine for pruritus","volume":"25","author":"Davis","year":"2003","journal-title":"J. Pain Symptom Manag."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/01.ASN.0000129336.09976.73","article-title":"Early and vigorous fluid resuscitation prevents acute renal failure in the crush victims of catastrophic earthquakes","volume":"15","author":"Gunal","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_89","first-page":"378","article-title":"Gabapentin: A promising drug for the treatment of uremic pruritus","volume":"18","author":"Naini","year":"2007","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21370","article-title":"Gabapentin in patients with the pruritus of cholestasis: A double-blind, randomized, placebo-controlled trial","volume":"44","author":"Bergasa","year":"2006","journal-title":"Hepatology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1440-1797.2012.01655.x","article-title":"Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: A prospective, crossover study","volume":"17","author":"Solak","year":"2012","journal-title":"Nephrology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/AAP.0000000000000326","article-title":"Effects of intrathecal \u03ba-opioid receptor agonist on morphine-induced itch and antinociception in mice","volume":"41","author":"Sakakihara","year":"2016","journal-title":"Reg. Anesth. Pain Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1213\/01.ANE.0000097168.32472.0D","article-title":"Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: An in vivo microdialysis study in human skin","volume":"98","author":"Blunk","year":"2004","journal-title":"Anesth. Analg."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1365-2133.2006.07191.x","article-title":"Transepidermal water loss, serum IgE and \u03b2-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis","volume":"154","author":"Lee","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1038\/jid.2009.188","article-title":"Histological characterization of cutaneous nerve fibers containing gastrin-releasing peptide in NC\/Nga mice: An atopic dermatitis model","volume":"129","author":"Tominaga","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000341268","article-title":"Efficacy and safety of a novel k-agonist for managing intractable pruritus in dialysis patients","volume":"36","author":"Kumagai","year":"2012","journal-title":"Am. J. Nephrol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/7\/1485\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:42:10Z","timestamp":1760208130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/7\/1485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,10]]},"references-count":96,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7]]}},"alternative-id":["ijms18071485"],"URL":"https:\/\/doi.org\/10.3390\/ijms18071485","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,10]]}}}